1. Home
  2. SURG vs TXMD Comparison

SURG vs TXMD Comparison

Compare SURG & TXMD Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo SurgePays Inc.

SURG

SurgePays Inc.

HOLD

Current Price

$1.28

Market Cap

28.6M

ML Signal

HOLD

Logo TherapeuticsMD Inc.

TXMD

TherapeuticsMD Inc.

HOLD

Current Price

$2.42

Market Cap

25.9M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
SURG
TXMD
Founded
2006
2008
Country
United States
United States
Employees
N/A
N/A
Industry
Advertising
Biotechnology: Pharmaceutical Preparations
Sector
Consumer Discretionary
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
28.6M
25.9M
IPO Year
N/A
N/A

Fundamental Metrics

Financial Performance
Metric
SURG
TXMD
Price
$1.28
$2.42
Analyst Decision
Strong Buy
Analyst Count
1
0
Target Price
$9.75
N/A
AVG Volume (30 Days)
339.5K
153.8K
Earning Date
11-12-2025
11-12-2025
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
N/A
0.03
Revenue
$50,372,555.00
$2,796,000.00
Revenue This Year
$3.78
$427.09
Revenue Next Year
$113.46
N/A
P/E Ratio
N/A
$106.16
Revenue Growth
N/A
75.19
52 Week Low
$1.05
$0.72
52 Week High
$3.47
$2.85

Technical Indicators

Market Signals
Indicator
SURG
TXMD
Relative Strength Index (RSI) 34.20 63.43
Support Level $1.16 $2.36
Resistance Level $1.35 $2.65
Average True Range (ATR) 0.15 0.26
MACD -0.07 0.04
Stochastic Oscillator 18.18 57.23

Price Performance

Historical Comparison
SURG
TXMD

About SURG SurgePays Inc.

Surgepays Inc is a fintech company focused on the underbanked community. It provides services to financial technology, telecommunications, and digital media companies. Its operating segment includes Mobile Virtual Network Operators that provide mobile broadband (internet connectivity), voice and SMS text messaging to both subsidized and direct retail prepaid customers through SurgePhone Wireless, LLC and Torch Wireless, LLC; Comprehensive Platform Services provide financial technology and a wireless top-up platform to independently owned convenience stores throughout the country; and Others. It generates the majority of its revenue from the Mobile Virtual Network Operators segment.

About TXMD TherapeuticsMD Inc.

TherapeuticsMD Inc is a pharmaceutical royalty company, currently receiving royalties on products licensed to pharmaceutical organizations that possess commercial capabilities in the relevant territories. The company and its subsidiaries (i) granted Mayne Pharma an exclusive license to commercialize its IMVEXXY, BIJUVA and prescription prenatal vitamin products sold under the BocaGreenMD and vitaMedMD brands (collectively, the "Licensed Products") in the United States and its possessions and territories, (ii) assigned to Mayne Pharma its exclusive license to commercialize ANNOVERA (together with the Licensed Products, collectively, the "Products") in the United States and its possessions and territories.

Share on Social Networks: